50
Growth Score
pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
4005583
CardiNor develops diagnostic assays based on the blood biomarker secretoneurin for cardiovascular disease risk stratification and prognosis.
About the Company
CardiNor develops diagnostic assays based on the blood biomarker secretoneurin for cardiovascular disease risk stratification and prognosis. The company focuses on secretoneurin testing to support identification of patients at risk of life-threatening arrhythmias, sudden cardiac death, and heart failure progression. Its CE-IVD-marked ELISA kit and
related assay formats are used to measure circulating secretoneurin concentrations in blood samples. CardiNor collaborates with hospitals, research groups, and distribution partners to validate and commercialize secretoneurin assays in clinical and research settings. The company emphasizes use of secretoneurin alongside established cardiac biomarkers such as troponin and BNP.
